An in silico analysis carried out by the group of Braganhol revealed also that both CD73 and CD39 are overexpressed in GBM tumor tissue compared to the normal brain or non-tumor brain tissue, illustrating that the expression of the purinergic system in GBM is different from the one expressed in non-tumor tissue. This evidence concerns the gene NT5E and neoplasm.